申请人:Millennium Pharmaceuticals, Inc.
公开号:US20170158686A1
公开(公告)日:2017-06-08
The present invention provides compounds useful as inhibitors of Raf protein kinase. The present invention also provides compositions thereof, and methods of treating Raf-mediated diseases.